共 61 条
[11]
Tavridou A(1995)Liver volume as a determinant of drug clearance in children and adolescents Drug Metab Dispos 23 1110-555
[12]
Suarez-Kurtz G(2000)Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children Clin Pharmacol Ther 68 541-713
[13]
Hamdy SI(2008)Oral anticoagulation with warfarin is significantly influenced by steroids and CYP2C9 polymorphisms in children with cancer Pediatr Blood Cancer 50 710-873
[14]
Hiratsuka M(2012)VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children Blood 119 868-867
[15]
Narahara K(2012)Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement Blood 119 861-299
[16]
Shahin MH(2011)Effect of the VKORC1 genotype on warfarin dose requirements in Japanese pediatric patients Drug Metab Pharmacokinet 26 295-990
[17]
Khalifa SI(2013)Genetic and clinical determinants influencing warfarin dosing in children with heart disease Pediatr Cardiol 34 984-1346
[18]
Gong Y(2008)Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics Pharmacogenomics 9 1331-undefined
[19]
El Din MS(undefined)undefined undefined undefined undefined-undefined
[20]
Amin DG(undefined)undefined undefined undefined undefined-undefined